Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
CRH
CRH
|
+$1.93B |
| 2 |
Texas Instruments
TXN
|
+$1.78B |
| 3 |
NVIDIA
NVDA
|
+$1.66B |
| 4 |
Starbucks
SBUX
|
+$1.15B |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$974M |
Top Sells
| 1 |
Apple
AAPL
|
+$3.13B |
| 2 |
Microsoft
MSFT
|
+$1.38B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.32B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.13B |
| 5 |
Procter & Gamble
PG
|
+$923M |
Sector Composition
| 1 | Technology | 33.53% |
| 2 | Consumer Discretionary | 10.88% |
| 3 | Financials | 10.79% |
| 4 | Communication Services | 9.25% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Ambac
AMBC
$413M
| $3.68M | ﹤0.01% |
287,239
+158,203
| +123% | +$2.03M |
|
1302
BrightSpring Health Services
BTSG
$4.69B
| $3.66M | ﹤0.01% |
322,092
+30,733
| +11% | +$349K |
|
1303
Gibraltar Industries
ROCK
$1.78B
| $3.66M | ﹤0.01% |
53,307
+9,789
| +22% | +$671K |
|
|
SWTX
1304
DELISTED
SpringWorks Therapeutics
SWTX
| $3.65M | ﹤0.01% |
97,031
+24,252
| +33% | +$913K |
|
1305
Algonquin Power & Utilities
AQN
$4.3B
| $3.65M | ﹤0.01% |
622,905
+73,680
| +13% | +$432K |
|
1306
TechnipFMC
FTI
$16.4B
| $3.63M | ﹤0.01% |
138,717
-35,699
| -20% | -$934K |
|
1307
Choice Hotels
CHH
$5.22B
| $3.63M | ﹤0.01% |
30,464
-17,892
| -37% | -$2.13M |
|
|
EVRI
1308
DELISTED
Everi Holdings
EVRI
| $3.62M | ﹤0.01% |
431,075
+34,804
| +9% | +$292K |
|
1309
Bankunited
BKU
$2.96B
| $3.62M | ﹤0.01% |
123,596
-95,259
| -44% | -$2.79M |
|
1310
NMI Holdings
NMIH
$3.08B
| $3.61M | ﹤0.01% |
106,190
-28,526
| -21% | -$971K |
|
1311
Icon
ICLR
$13.6B
| $3.6M | ﹤0.01% |
11,486
-86,676
| -88% | -$27.2M |
|
1312
Mr. Cooper
COOP
$14.1B
| $3.6M | ﹤0.01% |
44,305
-14,709
| -25% | -$1.19M |
|
1313
Upwork
UPWK
$2.24B
| $3.59M | ﹤0.01% |
334,215
-72,472
| -18% | -$779K |
|
1314
Monro
MNRO
$519M
| $3.58M | ﹤0.01% |
150,090
+117,370
| +359% | +$2.8M |
|
1315
Polaris
PII
$3.22B
| $3.55M | ﹤0.01% |
45,261
-48,442
| -52% | -$3.79M |
|
1316
CRISPR Therapeutics
CRSP
$5.12B
| $3.54M | ﹤0.01% |
65,620
-190,711
| -74% | -$10.3M |
|
1317
Viavi Solutions
VIAV
$2.69B
| $3.54M | ﹤0.01% |
515,368
-14,631
| -3% | -$101K |
|
1318
Upstart Holdings
UPST
$6.07B
| $3.53M | ﹤0.01% |
149,809
-420,240
| -74% | -$9.91M |
|
1319
Jazz Pharmaceuticals
JAZZ
$7.65B
| $3.51M | ﹤0.01% |
32,921
-65,135
| -66% | -$6.95M |
|
1320
Axalta
AXTA
$6.75B
| $3.51M | ﹤0.01% |
102,735
-155,413
| -60% | -$5.31M |
|
1321
Krystal Biotech
KRYS
$4.16B
| $3.51M | ﹤0.01% |
19,088
-2,526
| -12% | -$464K |
|
1322
Xerox
XRX
$463M
| $3.5M | ﹤0.01% |
301,606
+58,678
| +24% | +$682K |
|
1323
ScottsMiracle-Gro
SMG
$3.51B
| $3.5M | ﹤0.01% |
53,732
-30,536
| -36% | -$1.99M |
|
1324
ProShares S&P 500 ex-Health Care ETF
SPXV
$33.3M
| $3.49M | ﹤0.01% |
60,000
| – | – |
|
1325
SPDR Euro Stoxx 50 ETF
FEZ
$4.59B
| $3.49M | ﹤0.01% |
69,703
+12,257
| +21% | +$613K |
|